What changed
$CTVA — Develops and sells crop protection and seed products.
🎯 Q1 FY26 | Rev $5B | EPS $1.50 vs $1.18 🟢
💡 Consensus expects EPS of ~$1.18 for the quarter, but actual came in at $1.50, a 27% beat. The market likely views this as a one-time benefit from favorable weather or input costs, but the beat was driven by broad-based volume growth and margin expansion in seeds and crop protection.
🏢 Business Quality: 7/10 | Valuation: fair
📉 Reward/Risk: Upside 20% ($75 to $90) vs downside 10% ($75 to $67.50). Ratio: 2:1.
🔮 Catalyst: Event: Q2 2026 earnings (late July 2026). Timing: ~2 months. Metric to watch: Operating EBITDA vs guidance midpoint of ~$1.0B for Q2. Failure signal: If Q2 EBITDA comes in below $900M or management cuts full-year guidance.
💰 Entry: Current price $75 is attractive within 3% of support. Ideal entry: $72-75. Upside to $90+.
Also in play: $DIS $WBD $PARA $FOXA $NXST $CMCSA